NO20090322L - 6-(heterosykel-substituert benzyl)-4-oksoquinolin forbindelse samt anvendelse av det samme som IIIV integrave inhibitor - Google Patents

6-(heterosykel-substituert benzyl)-4-oksoquinolin forbindelse samt anvendelse av det samme som IIIV integrave inhibitor

Info

Publication number
NO20090322L
NO20090322L NO20090322A NO20090322A NO20090322L NO 20090322 L NO20090322 L NO 20090322L NO 20090322 A NO20090322 A NO 20090322A NO 20090322 A NO20090322 A NO 20090322A NO 20090322 L NO20090322 L NO 20090322L
Authority
NO
Norway
Prior art keywords
hiv
inhibitor
agent
compound
integrave
Prior art date
Application number
NO20090322A
Other languages
English (en)
Inventor
Hisashi Shinkai
Hiroshi Kawakami
Hiroshi Nakamura
Motohide Satoh
Hisateru Aramaki
Yuji Matsuzaki
Shuichi Wamaki
Masaki Yamashita
Masafumi Inoue
Original Assignee
Japan Tobacco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Tobacco Inc filed Critical Japan Tobacco Inc
Publication of NO20090322L publication Critical patent/NO20090322L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

hvori hvert symbol er som definert i beskrivelsen, eller et farmasøytisk akseptabelt salt derav, eller et solvat derav, og en farmasøytisk sammensetning, et anti-HIV-middel og en HIV-integraseinhibitor som inneholder slik forbindelse. Forbindelsen ifølge oppfinnelsen har en HIV-integraseinhiberingsaktivitet, og er anvendelig som et anti-HIV-middel, eller som et middel for profylakse eller behandling av AIDS. I tillegg, ved den kombinerte anvendelsen med andre anti-HIV-midler slik som en proteaseinhibitor, en revers transkriptaseinhibitor og lignende, kan den være et mer effektivt anti-HIV-middel. På grunn av at den viser integrasespesifikk høyinhiberingsaktivitet, kan forbindelsen være et farmasøytisk middel sikkert for menneskekroppen, som kun forårsaker noen få bivirkninger.
NO20090322A 2006-06-23 2009-01-21 6-(heterosykel-substituert benzyl)-4-oksoquinolin forbindelse samt anvendelse av det samme som IIIV integrave inhibitor NO20090322L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2006174331 2006-06-23
JP2006220082 2006-08-11
JP2006274143 2006-10-05
PCT/JP2007/062579 WO2007148780A1 (ja) 2006-06-23 2007-06-22 ６－（複素環置換ベンジル）－４－オキソキノリン化合物及びそのｈｉｖインテグラーゼ阻害剤としての利用

Publications (1)

Publication Number Publication Date
NO20090322L true NO20090322L (no) 2009-03-20

Family

ID=38833517

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20090322A NO20090322L (no) 2006-06-23 2009-01-21 6-(heterosykel-substituert benzyl)-4-oksoquinolin forbindelse samt anvendelse av det samme som IIIV integrave inhibitor

Country Status (19)

Country Link
US (1) US7872004B2 (no)
EP (2) EP2368880A1 (no)
JP (1) JP4038231B1 (no)
KR (1) KR101053811B1 (no)
AR (1) AR061583A1 (no)
AU (1) AU2007262010B2 (no)
BR (1) BRPI0713336A2 (no)
CA (1) CA2653830C (no)
CL (1) CL2007001838A1 (no)
CO (1) CO6150181A2 (no)
IL (1) IL195862A0 (no)
MX (1) MX2009000159A (no)
MY (1) MY144773A (no)
NO (1) NO20090322L (no)
NZ (1) NZ573709A (no)
PE (1) PE20080211A1 (no)
SA (1) SA07280343B1 (no)
TW (1) TW200811153A (no)
WO (1) WO2007148780A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004046115A1 (ja) * 2002-11-20 2004-06-03 Japan Tobacco Inc. ４−オキソキノリン化合物及びそのｈｉｖインテグラーゼ阻害剤としての利用
BRPI0716752A2 (pt) * 2006-09-12 2013-09-17 Gilead Sciences Inc processo e intermediÁrios para preparo de inibidores de intergrase
AR068403A1 (es) 2007-09-11 2009-11-18 Gilead Sciences Inc Proceso e intermediarios para la preparacion de inhibidores de integrasa
JP5624148B2 (ja) 2009-10-13 2014-11-12 エランコ・アニマル・ヘルス・アイルランド・リミテッド 大環状インテグラーゼ阻害剤
RU2567385C2 (ru) 2010-04-02 2015-11-10 ЯНССЕН Ар ЭНД Ди АЙРЛЭНД Макроциклические ингибиторы интегразы
CA3131037A1 (en) 2011-11-30 2013-06-06 Emory University Antiviral jak inhibitors useful in treating or preventing retroviral and other viral infections
NZ630199A (en) 2012-08-03 2016-12-23 Gilead Sciences Inc Process and intermediates for preparing integrase inhibitors
IL286328B1 (en) 2019-03-22 2026-04-01 Gilead Sciences Inc Tricyclic bridging compounds of carbamoylpyridone and their pharmaceutical use
CR20220418A (es) 2020-02-24 2022-10-10 Gilead Sciences Inc Compuestos tetracíclicos para el tratamiento de infecciones por vih
CA3192145A1 (en) 2020-09-30 2022-04-07 Gilead Sciences, Inc. Bridged tricyclic carbamoylpyridone compounds and uses thereof
JP7591155B2 (ja) 2021-01-19 2024-11-27 ギリアード サイエンシーズ， インコーポレイテッド 置換ピリドトリアジン化合物及びその使用
TWI856796B (zh) 2022-04-06 2024-09-21 美商基利科學股份有限公司 橋聯三環胺甲醯基吡啶酮化合物及其用途
CN115448866B (zh) * 2022-10-13 2023-11-21 中北大学 一种1-甲基-2,3,4,5-四硝基吡咯的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2321042T3 (es) 1997-09-15 2009-06-01 THE PROCTER & GAMBLE COMPANY Quinolonas antimicrobianas, composiciones y usos de las mismas.
WO2004004611A1 (en) 2002-07-08 2004-01-15 Coloplast A/S Conduit device
WO2004046115A1 (ja) 2002-11-20 2004-06-03 Japan Tobacco Inc. ４−オキソキノリン化合物及びそのｈｉｖインテグラーゼ阻害剤としての利用
EP1730135B1 (en) 2004-03-10 2010-09-22 The United States of America, represented by the Secretary, Department of Health and Human Services Qiunolin-4-ones as inhibitors of retroviral integrase for the treatment of hiv, aids and aids related complex (arc)
WO2005113509A1 (en) 2004-05-20 2005-12-01 Japan Tobacco Inc. Novel 4-oxoquinoline compound and use thereof as hiv integrase inhibitor
WO2006033422A1 (ja) 2004-09-21 2006-03-30 Japan Tobacco Inc. キノリジノン化合物、およびそのｈｉｖインテグラーゼ阻害剤としての利用
US7745459B2 (en) 2004-09-21 2010-06-29 Japan Tobacco Inc. Quinolizinone compound and use thereof as HIV integrase inhibitor
JP2006174331A (ja) 2004-12-20 2006-06-29 Fuji Xerox Co Ltd 画像圧縮装置、画像圧縮方法及びそのプログラム
JP2006220082A (ja) 2005-02-10 2006-08-24 Denso Corp 燃料噴射装置
JP4572720B2 (ja) 2005-03-30 2010-11-04 Ｄｉｃ株式会社 水分散型アクリル系樹脂の製造方法、並びにそれにより製造される水分散型アクリル粘着剤組成物及び粘着シート
DE102006005861A1 (de) 2006-02-09 2007-08-23 Aicuris Gmbh & Co. Kg Substituierte Chinolone III

Also Published As

Publication number Publication date
CL2007001838A1 (es) 2008-02-08
EP2033954A4 (en) 2009-08-12
US20080207618A1 (en) 2008-08-28
KR101053811B1 (ko) 2011-08-03
MX2009000159A (es) 2009-01-23
AR061583A1 (es) 2008-09-03
PE20080211A1 (es) 2008-04-23
EP2368880A1 (en) 2011-09-28
AU2007262010A1 (en) 2007-12-27
BRPI0713336A2 (pt) 2012-11-06
NZ573709A (en) 2011-04-29
CA2653830A1 (en) 2007-12-27
KR20090023731A (ko) 2009-03-05
JP2008110960A (ja) 2008-05-15
IL195862A0 (en) 2009-09-01
WO2007148780A1 (ja) 2007-12-27
JP4038231B1 (ja) 2008-01-23
EP2033954A1 (en) 2009-03-11
CA2653830C (en) 2011-11-22
SA07280343B1 (ar) 2011-01-15
TW200811153A (en) 2008-03-01
AU2007262010B2 (en) 2011-05-12
MY144773A (en) 2011-10-31
CO6150181A2 (es) 2010-04-20
US7872004B2 (en) 2011-01-18

Similar Documents

Publication Publication Date Title
TW200510425A (en) Nitrogen-containing fused ring compound and use thereof as HIV integrase inhibitor
MY144773A (en) 6-(heterocycle-susbtituted benzyl) -4-oxoquinoline compound and use of the same as hiv integrase inhibitor
MY136173A (en) 4-oxoquinoline compound and use thereof as hiv integrase inhibitor
NO20045152L (no) Ikke-nukleosid-reverstranskriptaseinhibitorer
NO20080913L (no) HIV-revers-transriptaseinhibitorer
MX2023002195A (es) Compuestos y metodos para el tratamiento de infecciones virales.
EA200970572A1 (ru) Ненуклеозидные ингибиторы обратной транскриптазы
NO20063958L (no) HIV integrase inhibitorer
MX2019007262A (es) Compuestos antivirales de bencilamina fosfodiamida.
NO20010743L (no) Antivirale indoloksoacetyl-piperazin-derivater
MA34002B1 (fr) Thérapie antivirale
CA2998646C (en) 4'-substituted nucleoside reverse transcriptase inhibitors and preparations thereof
UA114006C2 (xx) Похідні 5-фенокси-3h-піримідин-4-ону і їхнє застосування як інгібіторів зворотної транскриптази віл
GEP20156368B (en) Non-nucleoside reverse transcriptase inhibitors
CL2008003786A1 (es) Compuestos derivados de 1h-pirazolo[3,4-c]piridazinilo, 1h pirazolo[3,4-b]piridinilo, ah-pirazolo[3,4-c]piridinilo e indazolilo, inhibidores no nucleosidicos de la transcriptasa reversa del vih-1(nnrti); composicion fa<rma<ceutica que comprende a dichos compuestos; y su uso para tratar enfermedades mediadas por viv, sida o arc.
EA200601654A1 (ru) Ингибиторы интегразы вич
MX2021007069A (es) 3,3-difluoroalilaminas o sales de las mismas y composiciones farmaceuticas que comprenden las mismas.
GEAP202014873A (en) Methods for treatment and prophylaxis of hiv and aids
EA201170537A1 (ru) Ингибиторы вич-интегразы
EA202191711A1 (ru) Производные пиримидона в качестве селективных цитотоксических агентов против вич-инфицированных клеток
WO2016086153A3 (en) Use of hsp90 inhibitors for the treatment of hiv infections and aids
TW200738700A (en) HIV integrase inhibitors
SG155939A1 (en) Phosphoindoles as hiv inhibitors
WO2006083553A3 (en) Diketo acids with nucleobase scaffolds: anti-hiv replication inhibitors targeted at hiv integrase
MX2022011138A (es) Efecto contra coronavirus y aplicacion de inhibidor de fosfatidilinositol 4-cinasa.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application